The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for ...

Future challenges for rivaroxaban uptake in patients with AF include unfamiliarity with management of interruption and bleeding, and cost of the drug. The site of action of rivaroxaban and vitamin ...

CHICAGO, IL—Patients who develop thrombus in the left ventricle following myocardial infarction fare equally well when treated with rivaroxaban (Xarelto; Bayer/Janssen) as they do with warfarin, the ...

Rivaroxaban belongs to a newer class of drugs known as direct oral anticoagulants. As its blood-thinning effects are more predictable than those of warfarin, patients taking rivaroxaban don't need ...